The Mochudi Prevention Project ART Protocol

NCT01583439 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped Low Accrual.

Conditions

HIV Infections

Interventions

DRUG: highly active antiretroviral therapy: Lopinavir/Ritonavir, Lamivudine, Zidovudine, Efavirenz, Tenofovir Disoproxil Fumarate, Emtricitabine

Sponsor

Harvard School of Public Health (HSPH)

Collaborators

[object Object]